Twelve-Month Durability of Microbiota-Based Drug RBX2660 for Preventing Clostridioides difficile Infection (CDI) Is Not Associated With Patient Demographics: Sub-Population Analysis of a Phase 2 Open-Label Study Article
Full Text via DOI: 10.14309/01.ajg.0000600820.07183.be
Web of Science: 000509756006322